IDEAS home Printed from https://ideas.repec.org/a/wly/hlthec/v9y2000i8p659-667.html
   My bibliography  Save this article

Health economists meet the fourth tempter: drug dependency and scientific discourse

Author

Listed:
  • Steve Morgan
  • Morris Barer
  • Robert Evans

Abstract

No abstract is available for this item.

Suggested Citation

  • Steve Morgan & Morris Barer & Robert Evans, 2000. "Health economists meet the fourth tempter: drug dependency and scientific discourse," Health Economics, John Wiley & Sons, Ltd., vol. 9(8), pages 659-667, December.
    • Handle: RePEc:wly:hlthec:v:9:y:2000:i:8:p:659-667
    DOI: 10.1002/1099-1050(200012)9:8<659::AID-HEC578>3.0.CO;2-0
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/1099-1050(200012)9:83.0.CO;2-0
    Download Restriction: no
    File URL: https://libkey.io/10.1002/1099-1050(200012)9:8<659::AID-HEC578>3.0.CO;2-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Alan Maynard & Panos Kanavos, 2000. "Health economics: an evolving paradigm," Health Economics, John Wiley & Sons, Ltd., vol. 9(3), pages 183-190, April.
    2. Nick Freemantle & Alan Maynard, 1994. "Something rotten in the state of clinical and economic evaluations?," Health Economics, John Wiley & Sons, Ltd., vol. 3(2), pages 63-67, March.
    3. Reinhardt, Uwe E., 1997. "Making economic evaluations respectable," Social Science & Medicine, Elsevier, vol. 45(4), pages 555-562, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Vuorenkoski, Lauri & Toiviainen, Hanna & Hemminki, Elina, 2003. "Drug reimbursement in Finland--a case of explicit prioritising in special categories," Health Policy, Elsevier, vol. 66(2), pages 169-177, November.
    2. Paul Grootendorst, 2009. "Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation?," Social and Economic Dimensions of an Aging Population Research Papers 250, McMaster University.
    3. McMahon, Meghan & Morgan, Steve & Mitton, Craig, 2006. "The Common Drug Review: A NICE start for Canada?," Health Policy, Elsevier, vol. 77(3), pages 339-351, August.
    4. Maynard, Alan & McDaid, David, 2003. "Evaluating health interventions: exploiting the potential," Health Policy, Elsevier, vol. 63(2), pages 215-226, February.
    5. Don Husereau & Anthony Culyer & Peter Neumann & Philip Jacobs, 2015. "How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 273-279, June.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Maynard, Alan & McDaid, David, 2003. "Evaluating health interventions: exploiting the potential," Health Policy, Elsevier, vol. 63(2), pages 215-226, February.
    2. Clive Pritchard, 1998. "Trends in Economic Evaluation," Briefing 000444, Office of Health Economics.
    3. David Kernick, 2002. "Health economics: an evolving paradigm but sailing in the wrong direction? A view from the front line," Health Economics, John Wiley & Sons, Ltd., vol. 11(1), pages 87-88, January.
    4. Francis Pang & Mike Drummond & Fujian Song, 1999. "The use of meta-analysis in economic evaluation," Working Papers 173chedp, Centre for Health Economics, University of York.
    5. Hans-Georg Eichler & Sheldon Kong & Jean-Pierre Grégoire, 2006. "Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(2), pages 129-136, June.
    6. Miszczyńska Katarzyna M. & Miszczyński Piotr M., 2020. "Inpatient Costs in the Perspective of Polish Health Policy: Scenario Analysis," South East European Journal of Economics and Business, Sciendo, vol. 15(2), pages 43-56, December.
    7. Robinson, Ray, 1999. "Limits to rationality: economics, economists and priority setting," Health Policy, Elsevier, vol. 49(1-2), pages 13-26, September.
    8. Rhiannon Tudor Edwards, 2001. "Paradigms and research programmes: is it time to move from health care economics to health economics?," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 635-649, October.
    9. Damian Walker & Julia A. Fox‐Rushby, 2000. "Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature," Health Economics, John Wiley & Sons, Ltd., vol. 9(8), pages 681-698, December.
    10. Lessard, Chantale, 2007. "Complexity and reflexivity: Two important issues for economic evaluation in health care," Social Science & Medicine, Elsevier, vol. 64(8), pages 1754-1765, April.
    11. Maynard, Alan, 1999. "Rationing health care: an exploration," Health Policy, Elsevier, vol. 49(1-2), pages 5-11, September.
    12. Stephen Birch & Amiram Gafni, 2002. "On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales," Health Economics, John Wiley & Sons, Ltd., vol. 11(3), pages 185-191, April.
    13. Alan Maynard, 2007. "Translating Evidence Into Practice: Why Is It So Difficult?," Public Money & Management, Taylor & Francis Journals, vol. 27(4), pages 251-256, September.
    14. Maynard, Alan & Bloor, Karen, 1995. "Primary care and health care reform: the need to reflect before reforming," Health Policy, Elsevier, vol. 31(3), pages 171-181, March.
    15. Stephen Dunn, 2006. "Prolegomena to a Post Keynesian health economics," Review of Social Economy, Taylor & Francis Journals, vol. 64(3), pages 273-299.
    16. Ferrán Catalá-López & Adolfo Alonso-Arroyo & Rafael Aleixandre-Benavent & Manuel Ridao & Máxima Bolaños & Anna García-Altés & Gabriel Sanfélix-Gimeno & Salvador Peiró, 2012. "Coauthorship and Institutional Collaborations on Cost-Effectiveness Analyses: A Systematic Network Analysis," PLOS ONE, Public Library of Science, vol. 7(5), pages 1-9, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:9:y:2000:i:8:p:659-667. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.